NCT02506894View on ClinicalTrials.gov

Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Preterm Birth
Interventions
DRUG

Magnesium Sulfate

magnesium sulfate will be given for 24 hours

OTHER

0.9% sodium chloride solution

normal saline will be given as intravenous drip over 24 hours

Trial Locations (1)

Unknown

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT02506894 - Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection | Biotech Hunter | Biotech Hunter